Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3223-3228

  Secreto, Giorgio ^a   Zumoff, Barnett ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Androgens; Breast cancer; Review; Testosterone

Indexed keywords

ANDROGEN; ESTROGEN RECEPTOR; TESTOSTERONE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CLASSIFICATION; CANCER GROWTH; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; HORMONAL CARCINOGENESIS; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SHORT SURVEY; TESTOSTERONE BLOOD LEVEL;

ANDROGENS; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTORS, ESTROGEN;

EID: 84865677341     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (48)

1. Grattarola R: The premenstrual endometrial pattern of women with breast cancer. A study of progestational activity. Cancer 17: 1119-1122, 1964.
2. Grattarola R: Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women. Am J Obstet Gynecol 116: 423-428, 1973.
3. Grattarola R, Secreto G, Recchione C and Castellini W: Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol 118: 173-178, 1974.
4. Grattarola R: Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone excretion. J Natl Cancer Inst 56: 11-16, 1976.
5. Grattarola R: Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Res 38: 3051-3054, 1978.
6. Secreto G, Venturelli E, Pasanisi P and Berrino F: Androgens and breast cancer. The hyperandrogenic theory of breast cancer: past, present and future. In: Testosterone Research Trends. Ardis LI (ed). New York, Nova Science Publishers, pp. 105-138, 2007.
7. The Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies. J Natl Cancer Inst 94: 606-616, 2002.
8. Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A and Lenner P: Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes and Control 14: 599-607, 2003.
9. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks R, Toniolo P: Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90: 153-159, 2004.
10. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R and Riboli E: Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12: 1071-1082, 2005.
11. Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM and Cauleys JA: Sex Hormones, Risk Factors, and Risk of Estrogen Receptor-Positive Breast Cancer in Older Women: A Long-term Prospective Study. Cancer Epidemiol Biomarkers Prev 14: 1047-1051, 2005.
12. Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS and Lee JS: Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 103: 562-570, 2011.
13. James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel-Chaelon F, Chang-Claude J, Vrieling A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli, D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodríguez L, Buckland G, Sánchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita B, Ros MM, van Gils CH, Peeters PH, Khaw KT, Wareham N, Key TJ, Allen NE, Romieu I, Siddiq A, Cox D, Riboli E and Kaaks R: Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case control study. Cancer Prev Res 4: 1626-1635, 2011.
14. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz, AL, Brisken C, Fiche M, Delorenzi M and Iggo R: Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24: 4660-4671, 2005.
15. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C and Gerald WL: An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25: 3994-4008, 2006.
16. Secreto G and Zumoff B: Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy. Cancer Res 43: 3408-3411, 1983.
17. Secreto G, Oriana S and Recchione C: Ovariectomy alone or in combination with dexamethasone in patients with advanced breast cancer and high levels of testosterone or androstanediol secretion. Endocrine-Related Cancer 14: 55-58, 1984.
18. Preda F, Pizzoccaro G, Oriana S, Riboldi G, Severini A, Di Fronzo G, Secreto G and Grattarola R: Correlation between clinical response to bilateral oophorectomy, estrogen receptors and urinary androgen excretion in 49 patients with advanced breast cancer. Tumori 65: 325-330, 1979.
19. Oriana S, Secreto G, Severini A, Di Fronzo G, Di Giuseppe M, Valagussa P and Preda F: Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion. Breast Cancer Res Treat 2: 101-104, 1982.
20. Oriana S, Secreto G, Di Fronzo G and Torri A: Urinary androgens and tumor estrogen receptor as predictors of oophorectomy response and of survival in advanced breast cancer. Breast Cancer Res Treat 9: 201-205, 1987.
21. Rice BP and Savard K: Steroid formation in the human ovary. IV. Ovarian stroma compartment: formation of radioactive steroids from acetate-I-C14 and action of gonadotropins. J Clin Endocrinol Metab 26: 593-609, 1966.
22. Secreto G, Venturelli E, Meneghini E, Greco M, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A and Micheli A: Testosterone and biological characteristics of breast cancers in postmenopausal women. Cancer Epidemiol Biomarkers Prev 18: 2942-2948, 2009.
23. Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A and Micheli A: Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study. 2011, Int J Biol Markers 26: 241-246, 2011.
24. Van Landeghem AA, Poortman J, Nabuurs M and Thijssen JHH: Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45: 2900-2906, 1985.
25. Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F and Heuson JC: Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22: 515-525, 1986.
26. Santen RJ: Determination of tissue oestradiol in human breast cancer. Cancer Surv 5: 597-616, 1986.
27. Thijssen JHH and Blankenstein MA: Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. Eur J Cancer Clin Oncol 25: 1953-1959, 1989.
28. Mistry P, Griffiths K and Maynard PV: Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors. J Steroid Biochem 24: 1117-1125, 1986.
29. Recchione C, Venturelli E, Manzari A, Cavalleri A, Martinetti A and Secreto G: Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. J Steroid Biochem Molec Biol 52: 541-546, 1995.
30. Blankestein MA, Maitimu-Smeele I, Donker GH, Daroszewski J, Milewicz A and Thijssen JHH: Tissue androgen and the endocrine autonomy of breast cancer. J Steroid Biochem. Mol Biol 43: 167-171, 1992.
31. Pasqualini JR: Role of androgens in breast cancer. J Steroid Biochem Mol Biol 45: 167-172, 1993.
32. Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M and Sasano H: Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 63: 2762-2770, 2003.
33. Suzuki T, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S and Sasano H: 5α-Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 120: 285-291, 2007.
34. Suzuki T, Miki Y, Akahira J, Moriya T, Ohuchi N and Sasano H: Aromatase in human breast carcinomas as a key regulator of intratumur sex steroid concentrations. Endocr J 55: 455-463, 2008.
35. Nagasaki S, Miki Y, Akahira J, Suzuki T and Sasano H: 17β-Hydroxysteroid dehydrogenases in human breast cancer. Ann NY Acad Sci 1155: 25-32, 2009.
36. Suzuki T, Miki Y, Takagi K, Hirakawa H, Moriya T, Ohuchi N and Sasano H: Androgens in human breast carcinoma. Med Mol Morphol 43: 75-81, 2010.
37. Missmer SA, Eliassen AH, Barbieri RL and Hankinson SE: Endogenous estrogens, androgens, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96: 1856-65, 2004.
38. Woolcott CG, Shvetsov YB, Stanczyk FZ, Wilkens LR, White KK, Caberto C, Henderson BE, Le Marchand L, Kolonel LN and Goodman MT: Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer 17: 125-134, 2010.
39. Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD and Giles GG: Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 19: 492-502, 2010.
40. Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA and Denk H: Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 98: 703-711, 2003.
41. Ogawa Y, Hai E, Matsumoto K, Ikeda K, Tokunaga S, Nagahara H, Sakurai K, Inoue T and Nishiguchi Y: Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 13: 431-435, 2008.
42. Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, Park BW and Lee KS: Expression of androgen receptors in primary breast cancer. Ann Oncol 21: 488-492, 2010.
43. Micello D, Marando A, Sahnane N, Riva C, Capella C and Sessa F: Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers. Virchows Arch 457: 467-476, 2010.
44. Pascall JC: Post-transcriptional regulation of gene expression by androgens: recent observations from the epidermal growth factor gene. J Mol Endocrinol 18: 177-180, 1997.
45. Bhargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M and Chen B: EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol 18: 1027-1033, 2005.
46. Bergman MD, Schachter BS, Karelus K, Combatsiaris EP, Garcia T and Nelson JF: Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol. Endocrinology 130: 1923-1930, 1992.
47. Pink JJ and Jordan VC: Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330, 1996.
48. Stanisić V, Lonard DM and O'Malley BW: Modulation of steroid hormone receptor activity. Prog Brain Res 181: 153-176, 2010.